Root Financial Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.3K Buy
+510
New +$52.3K ﹤0.01% 1074
2026
Q2
– Sell
-696
Closed -$60.3K – 1734
2026
Q1
$60.3K Buy
696
+186
+36% +$16.3K ﹤0.01% 787
2025
Q4
$43.3K Buy
510
+240
+89% +$19.2K ﹤0.01% 775
2025
Q3
$19.6K Buy
+270
New +$18.6K ﹤0.01% 1132

Other funds holding IHE

Root Financial Partners's IHE Position: Q3 2026 in Review

Root Financial Partners opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 510 shares worth $51.3K. The stake represents ﹤0.01% of the portfolio and ranks #1074 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in IHE as recently as Q1 2026.

Root Financial Partners first reported a position in IHE in Q3 2025 and has held it in 4 quarters since. The position peaked at $60.3K in Q1 2026. 126 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Root Financial Partners held 510 shares of iShares US Pharmaceuticals ETF worth $51.3K as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new Root Financial Partners position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1074 holding.
  • Root Financial Partners first reported a position in iShares US Pharmaceuticals ETF in Q3 2025 and has held it in 4 quarters since.
  • Root Financial Partners's iShares US Pharmaceuticals ETF position peaked at $60.3K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.